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Abstract: Obesity is characterized by chronic and low-grade systemic inflammation, an increase of
adipose tissue, hypertrophy, and hyperplasia of adipocytes. Adipose tissues can be classified into
white, brown, beige and pink adipose tissues, which display different regulatory, morphological and
functional characteristics of their adipocyte and immune cells. Brown and white adipocytes can play a
key role not only in the control of energy homeostasis, or through the balance between energy storage
and expenditure, but also by the modulation of immune and inflammatory responses. Therefore,
brown and white adipocytes can orchestrate important immunological crosstalk that may deeply
impact the tumor microenvironment and be crucial for cancer establishment and progression. Recent
works have indicated that white adipose tissues can undergo a process called browning, in which
an inducible brown adipocyte develops. In this review, we depict the mechanisms involved in the
differential role of brown, white and pink adipocytes, highlighting their structural, morphological,
regulatory and functional characteristics and correlation with cancer predisposition, establishment,
and progression. We also discuss the impact of the increased adiposity in the inflammatory and
immunological modulation. Moreover, we focused on the plasticity of adipocytes, describing the
molecules produced and secreted by those cells, the modulation of the signaling pathways involved
in the browning phenomena of white adipose tissue and its impact on inflammation and cancer.
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1. Introduction
There is a strong correlation of cancer and obesity [1–3]. Considering the widespread occurrence
of obesity and associated diseases, such as several types of cancer [4], numerous efforts are ongoing to
lower the body weight gain through modulating the energy intake and/or expenditure [5]. It has been
demonstrated that intentional weight loss can be an important tool to prevent cancer incidence [6–9].
Obesity is characterized by a chronic low-grade inflammation, and during the weight loss-process
several changes in adipose organ can occur and modify the tissue’s composition and function, also
remodeling of the immune cell landscape [10]. Weight loss can increase the presence of brown-like
adipocytes in subcutaneous white adipose tissue, a process also known as browning or beiging [11],
and this may have a significant impact in tumor microenvironment [12]. White adipose tissue from
individuals with obesity can secrete a variety of inflammatory molecules that can strongly fuel
cancer. Whereas brown adipose tissue can a therapeutic potential against cancer [13]. Cancer cell
biology is directly affected by multiple cellular players present in the adipose tissue microenvironment.
Therefore, cancer establishment and progression may be differentially influenced the different types of
adipocytes, which have diverse morphologies and opposite functional roles (Figure 1). Since there are
numerous complex biological processes underlying adipose organ and obesity, a detailed and accurate
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understanding about how obesity affects tumor biology at the molecular and cellular levels, can be
useful to define the driving forces behind the obesity–cancer relationship.
Here, we will discuss the cellular and molecular pathways involved in the adipose organ plasticity
and their different impact in cancer progression.
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Figure 1. Adipocytes function in tumor progression. Adipocytes play a major role in the 
inflammatory modulation and endocrine function. It acts directly and/or indirectly on tumor 
progression, although some mechanisms are still unknown, such as the role of pink adipocytes on 
the tumor cells. The figure shows the great plasticity between brown, beige and white adipocytes 
with the influence of some inducers and the capacity of those cells to orchestrate the tumor 
microenvironment, through energy supply and immunomodulation. 
2. The Adipose Organ 
The adipose organ consists of several subcutaneous and visceral depots [14] of adipose tissues 
with metabolic, regulatory, and plastic roles [15]. This adipose organ is mainly composed by 
adipocytes and several other cells and components such as lymphocytes, macrophages, fibroblasts, 
endothelial cells, and extracellular matrix. In the areas where this organ is mainly composed by 
white adipocytes it is called white adipose tissue (WAT) and where brown adipocytes are 
predominant it is called brown adipose tissue (BAT). 
White adipocytes are characterized by its ability to store and release energy in form of lipids as 
a large and unilocular lipid droplet in the cytoplasm. WAT is the most abundant tissue in the body, 
and is not only related to the energy source of the body, but also acts as an important endocrine 
organ [16]. It is an active metabolic organ secreting several adipokines, such as leptin and 
adiponectin[17]. 
Brown adipocytes are characterized by the presence of high content of mitochondria and 
several small lipid droplets in the cytoplasm. BAT plays an important role in uncoupled respiration, 
via the uncoupling proteins (UCPs) present in their mitochondria. BAT is also a central location in 
the body for heat production (thermogenesis) [18] and it is deeply related to weight loss promotion 
[19]. It was initially believed that brown adipose tissue was found only in small mammals, 
hibernating animals and newborns. However, recent research has shown functional BAT present in 
adults at limited sites, such as the interscapular region and neck [20]. 
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2. The Adipose Organ
The adipose organ consists of several subcutaneous and visceral depots [14] of adipose tissues
with metabolic, regulatory, and plastic roles [15]. This adipose organ is mainly composed by adipocytes
and several other cells and components such as lymphocytes, macrophages, fibroblasts, endothelial
cells, and extracellular matrix. In the areas where this organ is mainly composed by white adipocytes
it is called white adipose tissue (WAT) and where brown adipocytes are predominant it is called brown
adipose tissue (BAT).
White adipocytes are characterized by its ability to store and release energy in form of lipids as a
large and unilocular lipid droplet in the cytoplasm. WAT is the most abundant tissue in the body, and
is not only related to the energy source of the body, but also acts as an important endocrine organ [16].
It is an active metabolic organ secreting several adipokines, such as leptin and adiponectin[17].
Brown adipocytes are characterized by the presence of high content of mitochondria and several
small lipid droplets in the cytoplasm. BAT plays an important role in uncoupled respiration, via the
uncoupling proteins (UCPs) present in their mitochondria. BAT is also a central location in the body
for heat production (thermogenesis) [18] and it is deeply related to weight loss promotion [19]. It was
initially believed that brown adipose tissue was found only in small mammals, hibernating animals
and newborns. However, recent research has shown functional BAT present in adults at limited sites,
such as the interscapular region and neck [20].
The adipose organ has prominent plasticity ability. White adipocytes can differentiate into
brown-like adipocytes in WAT [21] in a process called beiging. Beige adipocytes are characterized
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by their multilocular lipid droplet morphology, high number of mitochondria and the expression of
brown adipocytes genes (UCP-1, CIDEA, PGC1-α) [18]. Brown adipocytes raised in WAT are also
identified as brite. These brite (brown-in-white) adipocytes are also known as beige, inducible brown
or brown-like adipocytes [21]. Brite adipocytes can express UCP-1 and are originated in WAT in
response to various stimuli. For instance, large unilocular white adipocytes can differentiate into beige
adipocytes in response to cold or β3-adrenergic agonists [22]. However, these differentiated beige
adipocytes can lose UCP-1 expression after mice are moved back to warmer conditions, demonstrating
that the thermogenic profile of beige adipocytes is reversible [23].
A forth type of adipocytes has been described; the pink adipocytes [24,25]. Pink adipocytes
are milk-secreting alveolar cells that can arise from transdifferentiation of white adipocytes during
pregnancy and lactation. These cells are characterized by abundant cytoplasmic lipid droplets, apical
surface with microvilli, roundish and large nucleus centrally located, a robust rough endoplasmatic
reticulum (RER), Golgi complex, and milk-containing granules. Since the adipose organ acquires
a pink color during pregnancy and lactation, these epithelial glandular cells were named pink
adipocytes [24]. Evidence has supported the hypothesis of white-to-pink transdifferentiation,
pink-to-brown transdifferentiation, and reversible brown-to-myoepithelial cell conversion [25],
demonstrating once again the intense plasticity characteristic of adipose organ. The morphological
differences among white, brown, beige and pink adipocytes are summarized in Figure 2.
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its high amount of mitochondria enriched with UCP1 protein. Brown adipocytes have small fat 
droplets spread throughout the cell and have a high metabolic activity. Between the two extremes of 
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process in these cells, in order to reduce excessive fat accumulation, increase heat production and 
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Brown adipose tissue plays a major role in the hormonal regulation through the production 
and secretion of several adipokines, as well as the production of heat when exposed to cold. These 
characteristics were acquired throughout the evolution, turning possible the remodeling of white 
adipose tissue to beige/brown [30]. As previously described, BAT is characterized by a high number 
of mitochondria. In those organelles, located on the inner membrane, the amount of uncoupling 
protein 1 (UCP1) is enriched and its large number gives the brown color of the adipocytes [18]. 
Figure 2. Adipocytes cells and their main morphological and cellular activity differences. Adipocytes
are divided into four cell types that have different morphological and functional characteristics: the
white, pink, beige and brown adipocytes. The white adipocyte is described as a cell with great energy
storage ability, high pro-inflammatory profile, capable of producing several adipokines related to
inflammation modulation. The pink adipocyte is described as a cell with a great potential for energy
storage as well. However, this cell has a higher metabolic activity compared to white adipocytes, but
low ability to regulate inflammation, compared to white adipocytes. Unlike white adipocytes, the
brown adipocyte acts to maintain body temperature due to its high amount of mitochondria enriched
with UCP1 protein. Brown adipocytes have small fat droplets spread throughout the cell and have
a high metabolic activity. Between the two extremes of the white adipocyte to the brown, there is
the beige adipocyte. The beige adipocyte has the ability to produce heat due to the high number of
mitochondria, with the highest metabolic activity among all four types of adipocytes. Overall, the
figure shows the morphological difference between the adipocytes cells as well as indicate the capacity
t modula inflammation and the metabolic activity of adipocytes.
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Macrophages play an important role in adipose organ regarding the inflammation establishment.
As adipocytes, macrophages can change their phenotypes dependent on stimulus. Adipocytes can
recruit macrophages and polarize them to classical macrophage profile (M1) or alternative macrophage
profile (M2) depending on the adipocyte status of inflammation [26]. In this context, M1 macrophages,
characterized as pro-inflammatory, can induce Th1 response and strong microbicidal and anti-tumoral
activity. The M1 or classical macrophage are sources of pro-inflammatory cytokines such as TNF-α,
IL-1, IL-6, IL-12 and; and chemokines such as CXCL1–3, CXCL-5, and CXCL8–10. On the other hand,
M2 or alternative macrophage can promote Th2 response, tissue repair, Treg recruitment, and tumor
survival [27]. The levels of anti-inflammatory cytokines such as IL-10, IL-4 and TGF-β are elevated in
this phenotype, promoting a favorable microenvironment for tumor development. In the context of
tumor progression, the crosstalk between obese adipose tissue, macrophage polarization, and tumor
cells is crucial for struggle tumor progression [28].
3. Brown Adipocytes and the Browning Process
The increase of brown adipocytes in adipose organ promotes an anti-inflammatory phenotype
characterizing a healthy tissue development, decreasing insulin resistance, increasing thermogenesis,
and consequently reducing obesity. The adipose tissue, when exposed to certain stimuli, such as cold,
microbiota modifications [29] or adrenergic receptors (ADRB3) activation may undergo morphological
and functional changes, in which white adipose tissue acquires characteristics of brown adipose tissue.
This process is called browning [30]. The browning process has been highly studied due to its great
anti-obesity and anti-tumor pharmaceutical potential. Recent studies have sought to target receptors
in white adipocytes capable to induce the browning process in these cells, in order to reduce excessive
fat accumulation, increase heat production and struggle metabolic diseases related to obesity.
Brown adipose tissue plays a major role in the hormonal regulation through the production
and secretion of several adipokines, as well as the production of heat when exposed to cold. These
characteristics were acquired throughout the evolution, turning possible the remodeling of white
adipose tissue to beige/brown [30]. As previously described, BAT is characterized by a high number of
mitochondria. In those organelles, located on the inner membrane, the amount of uncoupling protein 1
(UCP1) is enriched and its large number gives the brown color of the adipocytes [18].
The UCP1 protein is responsible for the production of heat in the brown adipocytes and its presence
is increased in the browning process, being a great marker for the identification of the process [31].
Among the several factors capable to activate this protein in adipocytes and promoting thermogenesis,
is Norepinephrine signaling through β3-Receptors [32]. Norepinephine can interact with three different
types of receptors in brown adipose tissue. However, the interaction with β-adrenergic receptors is
better described. The signaling cascade of norepinephrine is mediated via adenylyl cyclase activation,
in which norepinephrine induces cAMP formation followed by a cascade of phosphorylation, including
the activated protein kinase A [33]. Protein kinase A, in turn, can phosphorylate some transcription
factors, including cAMP-response element binding protein (CREB) that will induce the transcription
of some genes, including the UCP1 gene. UCP1 uncouples electron transport from ATP production,
which in turn leads to controlled exothermic resolution of the electrochemical gradient and generation
of heat to maintain body core temperature [19].
An important factor that may contribute to the remodeling of adipose tissue is the role of hormones,
both paracrine and autocrine pathways. In addition to cold exposure, some hormones are produced
in response to activate β3-adrenergic receptor and promote browning. Among the most studied
hormones, we can mention catecholamines [34]. Peptide hormones such as fibroblast growth factor 21
(FGF21), are largely produced at lower temperatures and can bind to β3-adrenergic receptor, inducing
the brown adipocyte phenotype in WAT. Studies have shown the important physiological role of
FGF21 in the thermogenic process of WAT[35]. Mice deletion of FGF21 protein exhibits a large difficult
adaptation when exposed to cold, resulting from the less efficient remodeling of white adipocytes
to brown cells. FGF21 has the ability to act paracrine and autocrine in the adipocytes, to elevate the
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expression and activity of UCP1 in mitochondria. This regulation is due to the increase of adipose
tissue PGC-1α protein levels [36]. Expression of UCP1 is controlled by some factors including PGC-1α.
Thus, at low temperatures, the high production of FGF21 can induce the increase of UCP1 in adipocytes
by increasing the expression of PGC-1α protein levels independently of mRNA expression.
In addition to FGF21, we can highlight the adipokine leptin, known for its function on
hypothalamus receptors, controls energy expenditure and body weight. Leptin triggers browning
of WAT through a network innervation of sympathetic nervous system fibers in BAT and WAT.
Leptin promotes browning through peripheral and central mechanisms. Leptin-induced sympathetic
activation increases energy expenditure in BAT, also leading to browning in WAT. Leptin also acts in
skeletal muscle regulating of myogenic factors, such as the irisin, released after exercise, promoting
browning [37]. The blockage of neural sympathetic fibers located in inguinal WAT prevents the
development of brite adipocytes after cold exposure. The sympathetic tone is differentially regulated
in adipose depots [38].
Thyroid hormones (TH) also orchestrate a key role in browning of adipose tissue. Studies have
shown that THs act on the ventromedial nucleus of the hypothalamus (VMH) to inhibit AMP-activated
protein kinase (AMPK), thereby regulating the browning process in adipose tissue, leading to increased
thermogenesis and weight loss [39]. The participation of TH in this process has been experimentally
proven. Studies have shown that hypothyroid mice had significantly decreased in interscapular BAT
and hyperthyroid mice had significantly increased in this tissue activities, compared to euthyroid
controls [40]. Furthermore, THs can interact with norepinephrine by controlling the process. Among
factors that also may control UCP1 levels in adipose tissue is the concentration of triiodothyronine (T3)
in adipocytes. T3 can be generated by the conversion of thyroxine (T4) to T3 by type II iodothyronine
5’-deiodinase (DIO2). In adipose tissue cells, DIO2 is activated through the sympathetic nervous
system (SNS), in addition, adrenergic signals can be enhanced by THs which leads to an increase in
thermogenic precession by the activation of UCP1 due to the increase in T3 concentrations [41].
In summary, several mediators are capable to change the adipocyte phenotype, inducing the
production of some mediators that will act on the activation of UCP1 in the mitochondria of fat cells.
Some of these factors are being extensively studied due the role of brown cells in the maintenance of
tumor microenvironment, being a great target on the control of cancer progression.
4. Browning Process: Inductors and Mechanism
The multilocular distribution of lipids droplet, associated with the high amount of mitochondria,
besides the expression of some characteristic BAT genes such as Ucp1, proliferator-activated
receptor-gamma coactivator (Pgc1α) and Cidea, are some markers of the browning process [42].
The canonical process of browning in white adipose tissue begins with the sympathetic activation and
norepinephrine release that will act by binding to β-3 adrenergic receptors in adipose tissue. After
receptor activation, there is an increase in cAMP that will act by activating protein kinase A (PKA) [43].
Once activated, PKA will induce lipolysis by the phosphorylation of perilipin, which recovers the lipids
by protecting them from the action of lipases on adipose tissue cells, releasing fatty acids (FA) [44]. This
FA will be transported into mitochondria via carnitine palmitoyltransferase 1 (CPT1) which will then
act in some ways to produce heat [45]. FAs can act both to regulate the expression of genes associated
with thermogenesis, as well as to act regulating the activity of UCP1 proteins. After passing through the
β-oxidation, FADH and NADH electron carriers will be generated, which will pass through the electron
transport chain, generating a proton-motive force [46]. The protons pumped into the mitochondrial
matrix through UCP1 generates energy that is released as heat [47]. When inside the mitochondria, the
FAs also act modulating the activity of the UCP1s removing the purine inhibition, which generates an
influx of H+ protons into the mitochondrial matrix, uncoupling oxidative phosphorylation and energy
from the proton motive force dissipated as heat.
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Cellular changes occur in adipose tissue to induce the thermogenic process. Several factors
trigger the activation of β-3 adrenergic receptors increasing lipolysis, reducing the accumulation of FA
concomitant with increased expression and activity of the UCP1 protein, leading WAT to a BAT profile.
The thermogenesis process of adipose tissue is orchestrated by several transcription factors and
co-activators present in adipose tissue cells. These transcription factors act by regulating the genes
responsible for production and activation of the proteins that play an important role in the production
of heat and lipolysis of adipose tissues. Genetic transcription cascades have been widely studied and
the mechanisms of action of some transcriptional regulators are already well defined, both for WAT
and BAT [48]. Among the most studied regulators are mitochondrial protein transcription enhancers,
as well as proteins related to the stability and formation of lipid corpuscles [49].
Peroxisome proliferator-activated receptor gamma (PPARγ) coactivator 1-alpha (PGC1α) complex
is one of the main mechanisms of genetic regulation of the browning process [50]. Like most of the
browning process regulators of adipose tissue, this complex is induced by external stimuli such as
cold, exercise and fasting. The high concentration of PGC1α in adipose tissue is related to a higher
production of UCP1 in the cells, as well as the expression of enzymes, are important for the respiratory
chain in mitochondria [51]. Studies have shown that the specific tissue deletion of PGC1α followed by
submission to cold leads to a decrease in the body temperature [52]. These results suggest that PGC1α
exerts a role in the induction of browning, generating a physiological impact on the maintenance of
corporal temperature. Although PGC1α is increased in WAT in the browning process, PGC1α is not
required for differentiation of brown adipose tissue [53], however, PGC1α plays an important role
in insulin sensitivity in adipocytes. In addition, studies suggest that PGC1α-deficient cells have an
increased susceptibility to insulin resistance and type 2 diabetes in humans [54].
Regarding the importance of PGC1α in the remodeling of adipose tissue, there are several
transcriptional regulators that control browning [55]. Other co-inducers of genes that are related
to this process is PR (PRD1-BF1-RIZ1 homologous) -domain, containing 16 (Prdm16) [56]. In ob/ob
mice model, Prdm16 is down-regulated. The leptin-deficient mice showed hyperphagia, impairment
of insulin function, obesity and hypothermia. Prdm16 allows the activation of UCP-1 during BAT
differentiation and specific genes related to browning [57]. The high fat diet-induced obese rats
presented a downregulation of PRDM16 in a recent work which focused on physical activity and diets
to modulate browning phenotype [58].
PRDM16 has been described as an important transcriptional regulator regulating browning in
WAT [18]. Studies in mice have shown that an increase in the expression of PRDM16 is associated with
the differentiation of WAT to beige adipose tissue in addition to the decrease of metabolic diseases.
On the other hand, the deletion of this gene leads to a decrease in brown adipose tissue and an increase
in some metabolic syndromes such as obesity [59].
As with PGC-1α, PRDM16 activity is also increased in cold exposure by acting on genes related
to the production of mitochondrial-related proteins as well as in other gene regulators related to
heat production [60]. Studies have shown that different depots of adipose tissue in the body of the
organism have different abilities to undergo the browning process. Experimental data on murine
models have shown that both epidydimal and visceral have less browning ability compared to
subcutaneous WAT [61]. This different capacity of remodeling of the adipose tissue is due to the
presence of regulatory genes in the adipocytes [62]. PRDM16 is one of these important genes that are
found differentially in adipose tissues. PRDM16 can interact with WAT gene promoters by repressing
its activity. Carboxy-terminal binding proteins 1 and 2 (CtBP1/2) are examples of genes reported as
important promoters in WAT [63]. PRDM16 interact with these genes to inhibit the production of key
proteins for the differentiation and functioning of WAT. PRDM16 significantly augments the amount
of UCP1, CIDEA mRNA expression and FGF21 in epididymal WAT [62]. In addition, PRDM16 is
required together with PGC-1α in the activation of PPARγ [64]. Both BAT and WAT require PPARγ
for the differentiation and functionality of the adipocyte cells [65]. The post treatment with PPARγ
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agonist, rosiglitazone, shows an increase of UCP1 (main hallmark gene responsible for thermogenesis),
which BAT and WAT participation is related.
The molecular mechanisms of browning control of adipose tissue have been the subject of studies
for the development of pharmacological agents. Due to the key role of genes related to the biogenesis
of mitochondria, as well as β-adrenergic receptors and inducers of UCP1 expression, agonists have
appeared to induce WAT browning without the need for intensive exposure to cold and diets, through
the molecular modulation of the process, aimed against obesity.
Due to the potential target of brown adipose tissue in the use of fat stock to produce heat, and
consecutively to weight loss, ways of regulating the browning process of adipose tissue have been
studied. The development of new browning inducers, as well as the use of thyroid target drugs to
activate gene promoters has been described to boost WAT remodeling [66].
The practice of physical exercise modulate inflammatory factors in the body, including those
that can act on the regulation of adipose tissue, increasing mitochondrial biogenesis [67]. This
important regulatory ability turns physical exercise practice into a great contributor to the browning
process. The practice of exercise may start browning by reducing inflammation as well as increasing
pro-opiomelanocortin (POMC) neuron gene expression [68]. Initially, it was believed that POMC was a
homogeneous population and responded similarly to hormones and nutrients, however, studies have
shown its heterogenicity to responses to peripheral hormones, such as insulin and leptin responses [69].
Recent data have confirmed the performance of POMC in the browning process showing the synergistic
performance of POMC, leptin and insulin. The practice of physical activities leads to a hypothalamic
activation of the POMC population as well as a higher production of leptin and insulin that acted in
the adipocytes, stimulating some fundamental genes for the remodeling of WAT, such as Ucp1, Cidea
and Prdm16 [70]. In addition, periodic physical activity induces a greater production of FGF21 by
muscle cells, which will act on the adipose tissues, promoting the greater expression of PGC1α [71].
Recently, several studies have shown the importance of the gut microbiota in the initiation of the
browning process [29]. As well as the importance of physical exercises practice, the diet should also be
controlled to reach a healthy microbiota. The connection of the gut microbiota interfering with the
plasticity of adipose tissue became evident with the depletion of microbiota in mice, both with antibiotic
treatment and in germ-free mice (GF) [72]. The absence of gut microbiota induced a significant increase
in both inguinal subcutaneous and perigonadal visceral adipose tissue. The absence of the microbiota
induces a high level of IL-4 and IL-13, as well as an increase in circulating eosinophils [73]. Both the
presence of interleukin and eosinophils contribute to the attraction and polarization of macrophages to
the M2 profile. Alternative activation of macrophages has been described as a contributing agent of
the browning process in WAT, due to M2 polarization inducing the expression of tyrosine hydroxylase
(TH) [74]. This enzyme plays an active role in synthesizing catecholamines on adipocytes, promoting
lipolysis and consequently the production of heat through the mitochondria.
Furthermore, the gut microbiota triggers browning through the products of its metabolism. The gut
microbiota-initiated trimethylamine (TMA)/flavin-containing monooxygenase 3(FMO3)/trimethylamine
N-oxide (TMAO) pathway has been characterized as one of the major regulators of the process [75].
The flavin-containing monooxygenase 3 (FMO3) is a hepatic enzyme that, among its functions, acts on
the metabolism of metabolites gut microbe-derived TMA to produce TMAO. As the end product of
metabolism, circulating TMAO is indicative of cardiovascular disease [76]. In addition, high expression
of FMO3 is also associated with obesity, and FMO3 knockdown or genetic deletion showed a higher
positivity of UCP1 in WAT [77]. Although the role of the microbiota in the browning process is avid,
little is known about its pathways of induction. However, several studies have been conducted to
understand how products of bacteria metabolism induces browning of adipose tissue.
Further findings regarding the browning process induction pathways are making possible the
use of pharmacological agonists that may activate the browning process. In addition, to the practice
of physical activities, feeding and cold, hormonal regulators act at several key points in the body
promoting greater expression of UCP1 (Figure 3). The main target of browning induction is through β3
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adrenergic receptor [78]. CL 316,243 (disodium (R,R)-5-[2-[2-(3-chlorophenyl)-2-hydroxyethyl]amino]
propyl]-1,3-benzodioxole2,2-dicarboxylate) is a potent l-adrenergic agonist [79]. Considering that
β3-adrenergic receptor is significantly related to the onset of the browning process, the CL 316,243
(CL) has been studied as a potential anti-obesity treatment. CL-treated adipocytes have increased
UCP1 expression, as well as treatment reduced lipid storage in these cells, thus showing that CL
induced lipolysis in adipose tissue, followed by significant expression and activation of UCP1, leading
to heat production.
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system (CNS), which will act on β3 adrenergic receptors on adipocytes initiating the signaling cascade.
Activation of cAMP through the binding of catecholamines at adipocytes receptors will activate protein
kinase A (PKA), which will then induce lipid droplet lipolysis. This lipolysis will induce thermogenesis
by β oxidation in the mitochondria, as well as activation of the UCP1 protein, and the activation of
important genes linked to the browning process like peroxisome proliferator-activated receptor γ
(PPARγ), cAMP-response element binding protein (CREB) and Type II iodothyronine deiodinase (DIO2).
Similarly to the cold, the food also influences the thermogenic process by the production of metabolites
by the gut microbiota that will act both indirectly, acting in the liver, and directly in the adipocytes
inducing the activation of the UCP1 protein in the mitochondria. The liver and heart act in the process
being regulated by the practice of physical exercises increasing the release of fibroblast growth factor 21
(FGF-21), which will regulate the activity of the gene PGC1. In order to enhancer the process, several
agonist drugs are also used, both in the increase of β3 adrenergic receptors expression and in the
regulation of genes like PR (PRD1-BF1-RIZ1 homologous)–domain containing 16 PRDM16, acting
in the regulation of expression and activation of UCP1, which will then potentiate the thermogenic
process in the adipocytes, characterizing the browning process.
Due to the fundamental role of PPARγ in adipogenesis, the use of PPARγ ligands as a cell
differentiation control has become the target of several researches [80]. The role of PPARγ in lipid
modulation is well established. PPARγ cooperates with other transcription factor families, including
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the C/EBPs and SREBPs, to regulate adipocyte differentiation. The role of PPARγ increasing BAT was
shown by treatment with a potent PPARγ ligands such as rosiglitazone, an antidiabetic drug from
thiazolidinedione pharmaceutical class (TZD) [64]. The treatment with this agonist leads to an increase
in mitochondrial genes, such as UCP-1 and enzymes important for mitochondrial function such as
cytochrome c oxidase (Cox), subunit VIIIb (Cox8b), and subunit VIIa1 (Cox7a1). Thiazolidinediones
are important PPAR γ agonists leading to browning.[81]. TZD has been shown to be a major PPARγ
activator in white adipose tissue, leading to the induction of PRDM16 complex with PGC-1α/β [82].
Although WAT already has a basal production of PGC-1α/β, studies have shown a large increase in the
production of this protein, showing that increased activation of PPARγ via TZD can promote browning
in WAT, via PRDM16.
5. Cancer and Adipose Organ
Among the many functions of adipose tissue, its main role is the energy storage. Especially
the white adipose tissue, stores lipids in the form of triglycerides, to be used in the future as an
energy source. However, imbalance in the storage of lipids from fat cells can lead to a metabolic
dysfunction [83]. In view of the endocrine character of adipose tissue, a disorder may be associated
with various metabolic diseases such as cancers, cardiovascular as well as liver tissues. As already
described, adipose tissue is composed not only of adipocytes, but also of several other immune cells
that act to maintain the tissue homeostasis [84]. The polarization profile of these immune cells in the
tissue depends on the health status of the adipocytes. The type of inflammation predominant in the
tissue can be important to define malignancy progress. Immunological cells can be recruited and
polarized by external stimulus and modified to two different inflammatory profiles: type 1 and type 2
inflammatory phenotype [26]. The type 1 inflammation is described as a pro-inflammatory profile, and
the immune cells polarized to this kind of inflammation is responsible for release pro-inflammatory
cytokines such as TNF-α, IL-6, and IL-1β among another [85]. Deregulation on WAT leads to intense
macrophage recruitment through chemokines release, followed by the polarization of these cells to
M1 phenotype. The amount of CD8+ lymphocytes and natural killer are also increased in this tissue.
On the other hand, the type 2 of inflammation is characterized by the presence of anti-inflammatory
phenotypes, with the production and secretion of cytokines such as IL-10, IL-4, and TGF-β [86].
On the opposite way to type 1 inflammation, a higher amount of CD4+ lymphocytes and Treg cells
can be found in the anti-inflammatory type 2 profile [87]. The interplay between adipocytes and
immunological cells, such as macrophages and lymphocytes, may facilitate the establishment of several
pathologies [88] (Figure 4). White adipose tissue from people with obesity display a crucial role in the
increase of immunological cells infiltrate characterized by an intense presence of type 1 inflammation.
Thus, deregulation of adipose tissue leading to obesity, can promote immunological polarization
and adipokines and chemokines production. In addition, it can serve as energy source for tumor
cells proliferation. A study showed that the gene expression profile from periprostatic adipose tissue
of people with obesity and overweight patients is correlated with the risk for prostate cancer. The
results showed changes in genes regulating adipogenesis, lipolysis, apoptosis and proliferation. It was
observed that a downregulation of FADS1 (fatty acid desaturase) and an upregulation of LEP (gene
encoding leptin), which is associated with adipogenesis, lipogenesis and ANGTP1 (Angiopoietin
1), is associated with vascular development. Periprostatic adipose tissues of obese or overweight
patients presented altered expression of genes linked to adipose tissue activity, especially an increased
inflammatory profile [89]. There is a crosstalk of adipose tissues and carcinomas through an increase of
angiogenesis corroborated by higher expression of VEGF, proinflammatory cytokines such as IL-6 and
TNF-α. The WAT, specially the visceral WAT, exerts a central role to develop a pro-tumoral secretome,
associated to a higher risk for cancer in obesity [90].
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in the deg ne ation process, inducing their death with the release of cytoplasmic components into the
extra cellular environment, this fact increases inflammation in the tissue, where more macrophages will
be recruited and polarized. The lease of cell-free DNA (cfDNA) by necrotic adipocytes inc ase the
macrophages recruitment, which will then be polarized. In addition, the rel ase of free fatty acids (FFA)
may favor the d velopment f some met bolic dis ases su h as cancer. Unlike healthy tissue, where a
larger acrophage population is found in its M2 profile and CD4+ T cells maintaining tissue homeostasis,
the obese tissue has an increased presence of CD8+ T cells, favori g the inflammatory process.
The dysfunction of adipose tissue, due to obesity, associated with the tumor is characterized
as a worse prognosis [91]. Due to the fact that obese adipose tissue is linked to an inflammatory
condition, the modulation of the tumor microenvironment is influenced by the production of cytokines
by adipocytes as well as immunological cells that are recruited and polarized at the site [92]. Obesity
shows a deregulation of adipokines secretion, specially promoting a pro-inflammatory profile, as
a result of higher adiposity and adipocytes dysfunction. In addition to the secretion of cytokines,
adipokines are related to lipid metabolism, glucose and cardiovascular homeostasis. There is a
group represented by acute-phase reactants, as C-reactive protein, plasminogen activator inhibitor 1,
haptoglobin and amyloid A serum. The chemokines also exert a differential role, with higher secretion
of MCP-1, CCL2, CCL5, MIP-2 (macrophage inflammatory protein-2). In addition to these factors,
damage-associated molecular pattern (DAMP) or alarmins as HMGB1, heat shock proteins, tenascin C.
Altogether, it can lead to an inflammatory microenvironment in obesity [93]
Cancers in general require a favorable environment for their progress as well as energy sources,
as result of their high metabolic activity. Obese adipose tissue can provide these tumor growth
and development factors through the large production of cytokines such as TNF-α, IL-6, IL-1β, and
CCL2 [94]. These cytokines, among other functions, can establish an inflammatory environment by
the recruitment of lymphocytes and macrophages. Once recruited into the tumor microenvironment
(where there is interaction between adipocytes, matrix and tumor cells) by the deregulated adipocytes,
macrophages tend to be polarized to their anti-inflammatory M2 profile by tumor cells [26]. Most
tumors are characterized by high production of IL-4, IL-10 and IL-13. The association between
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the intense release of anti-inflammatory cytokines with the production of the chemokine leads to a
substantial macrophage polarization on the tumor microenvironment. Once in the tumor site, the
M2 macrophage profile is controlled by the tumor cells, in addition to an inhibition of the activity of
anti-tumor immune cells, such as inhibition of TCD 8+ lymphocyte and NKT activation [95]. Moreover,
adipocytes also play a role in this process. Studies have shown a significant reduction of macrophages
in CCL2 knockout mice in the obesity-induced model [96]. This inflammatory profile is aggravated
by the large infiltration of macrophages in WAT due to high levels of cell-free DNA (cfDNA). Obese
adipose tissue in degeneration processes release DNA into the extracellular environment that leads to
macrophage accumulation in the tissue [97]. Once in the tissue, macrophages can be polarized to the M1
profile leading to the formation of crown-like structures (CLS) [98]. Such structures are formed by the
accumulation of macrophages M1 around adipocytes in degeneration. The macrophages then induce
the death of these adipose, which leads to the release of cell components in the tissue, aggravating
the inflammation. Furthermore, the cell death of these adipocytes will trigger the release of the fatty
acids to the extracellular environment, which will be used as energy source by tumor cells [99]. Thus,
obese white adipose tissue has an intimate relationship with the tumor, where there is the attraction
of macrophages that will be, consecutively, polarized by the tumor as well as by the adipose tissue,
aggravating the inflammatory state and favoring the tumor. Of note, adipose-derived stromal cells
(ASCs) represent a crucial coadjuvant in the context of cancer development [100]. Desmoplasia, the
extracellular matrix and stromal microenvironment remodeling process, impacts significantly on local
inflammation, causing homeostasis disruption and facilitating the malignancy process [101]. On the
tumor microenvironment, the extracellular matrix is stiffer than normal tissues. This happened in
function of the high activity of myofibroblasts, the principal soldier in the desmoplasia process [12].
During the obesity, there is a significant increase in the myofibroblasts, which will acts depositing
stiff matrix components such as fibronectin and fibrillar collagen, supporting the tumor establishment
and inducing fibrosis on WAT [102]. ASCs, or just pre-adipocytes, have been described as a target to
tumor progression because of the multipotent mesenchymal progenitor action. Tumor cells can release
cytokines and chemokines such as IL-8 and growth-related α-protein (CXCL1), respectively. These
cytokines and chemokines will recruit ASCs from WAT into the tumor microenvironment [103]. People
with these two metabolic diseases, obesity and cancer, have been reported presenting a dysfunction
on the IL-8 production, releasing higher amount of this cytokines by the tumor cells, resulting in an
excessive ASCs recruitment to the tumor site. Once in the site, malignant cells induce the differentiation
of ASCs into myofibroblasts via transforming growth factor-β (TGFβ)–mitogen-activated protein
kinase (MAPK) signaling [104]. The presence of ASCs cells are related to a worse prognostic. Besides
the ability to remold the extracellular matrix, the myofibroblasts can also give support to tumor cells
by producing VEGF and inducing angiogenesis [104]. Moreover, cancer cells that remain following
surgery can induce resident ASCs to promote tumor angiogenesis, exacerbating cancer growth and
aggressiveness [105]. This is an important point to be considered, especially regarding the use of
adipose tissue engraftment to build up the mammary glands following mastectomy surgeries.
Although the negative regulation that obese adipose tissue associated with the tumor may
cause, the exacerbated secretion of leptin by adipose tissue form may be a crucial factor for cancer
progression [106]. Leptin is mainly produced by adipocytes, although levels of leptin have already
been detected by other tissues, such as skeletal tissue and placenta, but at lower levels. The main role
of leptin is the regulation of appetite, acting on the central nervous system, reducing the appetite [107].
Leptin acts predominantly by binding to the full-length receptor OB-Rb, which will then induce the
activation of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway,
which will then induce the activity of phosphatidylinositol 3- kinase (PI3K) which promotes cellular
growth, migration and invasion. In addition, the deregulated production of leptin by obese adipocytes
leads to the production and secretion of inflammatory cytokines such as TNF-α and IL-6 by macrophage,
modulating the polarization of lymphocytes, with the shifts the T-helper (TH) balance toward TH1 [108].
This action of leptin remodeling the tumor microenvironment has been increasingly studied, due to
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its great importance establishing low grade inflammation in obese individuals, increasing the risks
of cancer.
Due to the great functionality of BAT and its high metabolic activity in the control of energetic
homeostasis, this tissue has been studied for its ability to influence tumors development. This
thermogenic capacity, the induction of lipolysis as well as the modulation of the inflammatory profile,
are the main targets of the studies. Experimental analyses have shown a link between a super expression
of anti-tumor genes and an increase of brown adipocytes cells in the adipose organ. One of the genes
linked with browning and cancer is the PTEN gene. The PTEN gene acts on the regulation of cell growth
and proliferation, being one of the most important anti-tumor regulators. This gene is considered a
tumor suppressor for the action of its phosphatase protein product that is related with the regulation
of cell cycle and the reduction of cell proliferation. With this in mind, a study demonstrated that
overexpression of PTEN gene triggered resistance to cancer, energy expenditure and insulin resistance
in mice [109]. In addition, the mice had high expression of UCP1, showing high BAT activity [109].
Although BAT has been reported as a healthy tissue, recent studies have shown its relation to cancer
cachexia [110]. Cancer-associated cachexia (CAC) is a complex, multifactorial syndrome characterized
by the loss of adipose and skeletal muscle tissues that leads to great weight loss, which is associated
with a negative impact on patients’ survival. Studies in animal model of cachexia showed a great
increase in the expression of genes associated with the browning process, such as UCP-1, Prdm16 and
Pgc1α in patients with cancer [111]. Although this relationship with BAT promoting cancer-associated
cachexia, suggesting adipose tissue dysfunction associated with a worse prognosis, further studies
should be done to better elucidate the function of BAT in the tumor establishment.
The pink adipose tissue arises during lactation, changing the breast tissue microenvironment
and promoting impact on the modulation of local immune cells [25]. Therefore, pink adipocytes
could have a direct influence in breast cancer establishment. In breast tissue, white adipocytes can
transdifferentiate into pink adipocytes, in a process called pinking, which is a reversible phenomenon.
During this process, mammary epithelial secretory cells can lose the expression of PPARγ creating a
pro-breast tumorigenic microenvironment [112], facilitating the establishment of breast cancer at this
phase. However, the function of the pink fat cells on cancer progress, especially on breast cancer, need
to be better characterized.
6. Conclusions
As a metabolic syndrome, people with obesity show a deregulation on the inflammatory profile.
Changes of cytokines and adipokines secretion by adipocytes on the adipose organ may influence
the immune system response, which is related to a worse prognostic on cancer development. In this
context, the modulation of adipose organ has been studied, looking for a better treatment to use in
association with a conventional treatment against cancer [113].
The white adipose tissue has been deeply implicated in cancer, whereas the increase of this tissue is
highly related to a pro-tumorigenic microenvironment. Several pre-clinical, clinical and epidemiologic
data [90] suggest that the increase of WAT characteristics is accompanied by a growth-promoting and
pro-inflammatory microenvironment linked to increased cancer risk and/or progression.
BAT can work as a double-edged sword during obesity, since the induction of browning of
the WAT can be a powerful tool to reduce the weight of people with obesity, facilitate weight loss
and improve metabolic health, as we previously mentioned here. At the same time, the reduction
of activation of the BAT can soften the cachexia status of an individual by inducing weight gain in
muscle and increasing muscle mitochondrial biogenesis. Then, this last characteristic of BAT can be of
great importance in cancer perspective. The inhibition of browning of the WAT can ameliorate the
severity of cachexia that can occur in several types of cancer by increasing the energy expenditure [114].
Therefore, treatments that associate the reduction of inflammation with the blockade of β-adrenergic
receptors could potentially ameliorate the severity of cachexia by reducing the browning of WAT.
On the other hand, the activation of the brown adipose metabolism, as well as the induction of the
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browning of the WAT, can improve insulin resistance, reduce inflammation and increase the secretion
of anti-inflammatory molecules, creating anti-tumorigenic microenvironment.
The plasticity of adipose organ components has been a target of the pharmaceutical industry and
the medical research, aiming for the profile remodeling of the fat cells to a medicinal anti-cancer target.
Therefore, the adipose organ is highly plastic, and this plasticity may be a useful pharmacological tool
to combat cancer progression and support cancer therapeutic treatments.
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